Results 111 to 120 of about 14,868 (228)

α-synuclein seed amplification assay sensitivity may be associated with cardiac MIBG abnormality among patients with Lewy body disease

npj Parkinson's Disease
Although α-synuclein seed amplification assays (α-syn SAA) are promising, its sensitivity may be affected by heterogeneity among patients with Lewy body disease (LBD). We evaluated whether α-syn SAA sensitivity is affected by patient heterogeneity, using
Masanori Kurihara, Katsuya Satoh, Ryosuke Shimasaki, Keiko Hatano, Kensuke Ohse, Kenichiro Taira, Ryoko Ihara, Mana Higashihara, Yasushi Nishina, Masashi Kameyama, Atsushi Iwata   +10 more
doaj   +1 more source

Phaeochromocytoma in children [PDF]

, 2002
Phaeochromocytoma is a rare disease in childhood with a subtle and wide range of clinical presentations. We report two confirmed cases and one potential case of phaeochromocytoma, each belonging to a different disease spectrum or syndromal disorder ...
Cheung, PT, Kwan, EYW, Low, LCK, Yeung, LPK   +3 more
core  

Secondary childhood acute myeloid leukemia with complex karyotypic anomalies including monosomy 7, monosomy 5 and translocation (1;10) after 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma

The Turkish Journal of Pediatrics, 2011
The prognosis for relapsing or refractory neuroblastoma (NB) remains dismal, with a five-year disease-free survival of < 20%, and no effective salvage treatment has been identified so far.
Sonay Incesoy-Ozdemir, Ceyhun Bozkurt, Nazmiye Yüksek, Ayşe Ceyda Oren, Gürses Sahin, Süreyya Bozkurt, Ulya Ertem   +6 more
doaj  

MIBG

, 2010
Jeremy Jones, Arlene Campos, Scott McKinnon   +2 more
openaire   +1 more source

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy

Chinese Journal of Contemporary Neurology and Neurosurgery, 2014
Background 131I-metaiodobenzylguanidine (131I-MIBG) can be intaked by cardiac sympathetic postganglionic fibre, thus becomes the imaging agent to evaluate cardiac sympathetic nerve function. The aim of this study is to investigate the autonomic nerve
Li WANG, Tuan-feng YANG, Min CHENG, Yuan LI, Qian WANG, Jin-song JIAO, Wei-hong GU, Kang WANG, Miao JIN, Huai-lian GUO   +9 more
doaj  

131I-MIBG myocardial scintigraphy in patients with Parkinson's disease

Chinese Journal of Contemporary Neurology and Neurosurgery, 2016
Background 131I-metaiodobenzylguanidine (131I-MIBG), which can be taken by cardiac sympathetic postganglionic fibers, is an imaging agent to assess the cardiac sympathetic nerve function.
Tuan-feng YANG, Li WANG, Yuan LI, Min CHENG, Jin-song JIAO, Qian WANG, Huai-lian GUO   +6 more
doaj  

Simplified dosimetry using two-time-point kinetic modeling of ¹²⁴I-MIBG PET for ¹³¹I-MIBG therapy in neuroblastoma. [PDF]

Med Phys
Wang Y, Huh Y, Matthay KK, Vo KT, Pampaloni MH, DuBois SG, Seo Y.   +6 more
europepmc   +1 more source

Drug interactions involving therapeutic radiopharmaceuticals: a systematic review. [PDF]

EJNMMI Radiopharm Chem
Gacon R, Chapuis R, Fabris-Davet L, Ranjit N, Goutelle S, Bourguignon L, Flaus A, Bolot C, Levigoureux E, Gallet M, Chaib S.   +10 more
europepmc   +1 more source

Synthesis, Radiochemical Characterization, and Biodistribution of a ¹⁸⁸Re Analogue of [¹³¹I]mIBG in a Neuroblastoma Xenograft Model. [PDF]

J Labelled Comp Radiopharm
Sakhare N, Kumar D, Das S, Mitra A, Mirapurkar S, Rani G, Sheela M, Chirayil V, Mohanty B, Mathur A, Mallia MB, Chaudhari P.   +11 more
europepmc   +1 more source

Clinical applications and future directions of Iodine-131-Metaiodobenzylguanidine therapy in neuroblastoma: from salvage treatment to frontline integration. [PDF]

Ann Nucl Med
Vu HMC, Kayano D, Wakabayashi H, Kuroda R, Kinuya S.   +4 more
europepmc   +1 more source